title: Molecular docking studies of quercetin and its analogues against human inducible nitric oxide synthase.
abstract: Nitric oxide synthases (NOS) catalyze to produce nitric oxide (NO) from L-arginine. The isoform of NOS i.e. inducible nitric oxide synthases (iNOS) expression is observed in various human malignant tumors such as breast, lung, prostate and bladder, colorectal cancer, and malignant melanoma. Also an increased level of iNOS expression and activity has been found in the tumor cells of gynecological malignancies, stroma of breast cancer and tumor cells of head and neck cancer. Because of its importance in causing tumors and cancer, iNOS enzyme has become a new target in finding novel inhibitors as anti cancer agents. The present work focuses on the molecular docking analysis of quercetin and its analogues against iNOS enzyme. Earlier there are reports of quercetin inhibiting iNOS enzyme in certain experiments as anti cancer agent. But the clinical use of quercetin is limited by its low oral bioavailability and therefore needed its molecular modification to improve its pharmacological properties. In the present study ten analogues of quercetin were found to be docked at the active site cavity with favorable ligand-protein molecular interaction and interestingly from the ADME-Toxicity analysis these analogues have enhanced pharmacological properties than quercetin.
authors.affiliation: Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, 784028 Assam India.
authors.forename: Salam Pradeep
authors.initials: SP
authors.lastname: Singh
authors.forename: Bolin Kumar
authors.initials: BK
authors.lastname: Konwar
keywords: Analogues; Cancer; Inducible iNOS; Molecular docking; Molecular modification
references.citation: Urol Res. 2001 Feb;29(1):23-8
references.pmid: 11310211
references.citation: J Exp Med. 1992 Aug 1;176(2):599-604
references.pmid: 1380065
references.citation: Cancer Res. 1994 Mar 1;54(5):1352-4
references.pmid: 7509718
references.citation: Chem Res Toxicol. 2005 Dec;18(12):1907-16
references.pmid: 16359181
references.citation: Virchows Arch. 2000 Feb;436(2):109-14
references.pmid: 10755599
references.citation: J Med Chem. 2006 Jun 1;49(11):3315-21
references.pmid: 16722650
references.citation: J Cell Biochem. 2001;82(4):537-48
references.pmid: 11500931
references.citation: J Natl Cancer Inst. 1999 Jan 6;91(1):86-8
references.pmid: 9890175
references.citation: Scand J Gastroenterol. 2000 Nov;35(11):1204-11
references.pmid: 11145294
references.citation: J Surg Oncol. 1999 Apr;70(4):222-9
references.pmid: 10219017
references.citation: Environ Mol Mutagen. 2004;44(1):3-9
references.pmid: 15199542
references.citation: Head Neck. 2002 Jan;24(1):16-23
references.pmid: 11774398
references.citation: J Clin Invest. 1997 Nov 1;100(9):2146-52
references.pmid: 9410890
references.citation: Annu Rev Immunol. 1997;15:323-50
references.pmid: 9143691
references.citation: Yakugaku Zasshi. 2008 Dec;128(12):1845-9
references.pmid: 19043305
references.citation: FEBS Lett. 1994 Nov 21;355(1):23-6
references.pmid: 7525358
references.citation: J Natl Cancer Inst. 1998 Apr 15;90(8):587-96
references.pmid: 9554441
references.citation: Life Sci. 2001 Jan 12;68(8):921-31
references.pmid: 11213362
references.citation: Br J Cancer. 1995 Jul;72(1):41-4
references.pmid: 7541238
references.citation: Mol Cancer Ther. 2003 Aug;2(8):815-23
references.pmid: 12939472
references.citation: Nat Struct Biol. 1999 Mar;6(3):233-42
references.pmid: 10074942
references.citation: Clin Cancer Res. 2000 Dec;6(12):4739-44
references.pmid: 11156228
references.citation: Anticancer Res. 2001 Jul-Aug;21(4B):3101-6
references.pmid: 11712818
references.citation: EMBO J. 1999 Nov 15;18(22):6260-70
references.pmid: 10562538
references.citation: Exp Ther Med. 2012 Feb;3(2):249-254
references.pmid: 22969877
references.citation: Cancer Lett. 2008 Oct 8;269(2):315-25
references.pmid: 18467024
references.citation: Nutr Cancer. 2007;59(2):152-62
references.pmid: 18001209
references.citation: Acta Physiol Scand. 2001 Sep;173(1):119-26
references.pmid: 11678734
references.citation: Clin Cancer Res. 2000 Jun;6(6):2408-16
references.pmid: 10873093
references.citation: Mutat Res. 2004 Nov 2;555(1-2):107-19
references.pmid: 15476855
references.citation: J Immunol. 1997 May 15;158(10):4938-46
references.pmid: 9144512
references.citation: Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):3-26
references.pmid: 11259830
references.citation: Cell Res. 2002 Dec;12(5-6):311-20
references.pmid: 12528889
references.citation: Curr Opin Chem Biol. 1998 Oct;2(5):656-63
references.pmid: 9818193
references.citation: J Urol. 1999 Feb;161(2):630-4
references.pmid: 9915473
references.citation: Org Biomol Chem. 2006 Mar 21;4(6):1154-9
references.pmid: 16525561
references.citation: Cancer Res. 1998 Jan 15;58(2):334-41
references.pmid: 9443414
references.citation: Proteins. 2004 May 1;55(2):288-304
references.pmid: 15048822
references.citation: Curr Drug Targets Inflamm Allergy. 2002 Mar;1(1):89-108
references.pmid: 14561209
references.citation: Nat Med. 1998 Dec;4(12):1371-6
references.pmid: 9846573
references.citation: J Pathol. 2001 Jun;194(2):194-200
references.pmid: 11400148
references.citation: Nucleic Acids Res. 2010 Jan;38(Database issue):D255-66
references.pmid: 19933261
references.citation: BJU Int. 2000 Aug;86(3):234-9
references.pmid: 10930922
references.citation: Oncol Rep. 2001 Nov-Dec;8(6):1275-9
references.pmid: 11605048
references.citation: J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49
references.pmid: 11274893
references.citation: Genomics. 1994 May 15;21(2):419-22
references.pmid: 7522210
references.citation: Ann R Coll Surg Engl. 2002 Mar;84(2):75-8
references.pmid: 11995767
references.citation: Mutat Res. 2005 Jul 1;574(1-2):124-38
references.pmid: 15914212
references.citation: Biochem J. 1994 Mar 1;298 ( Pt 2):249-58
references.pmid: 7510950
references.citation: Annu Rev Physiol. 1995;57:683-706
references.pmid: 7539993
references.citation: Proc Natl Acad Sci U S A. 1996 Mar 19;93(6):2442-7
references.pmid: 8637893
references.citation: Cancer Res. 2001 Jan 15;61(2):419-22
references.pmid: 11212223
references.citation: Eur J Pharmacol. 2007 Feb 28;557(2-3):221-9
references.pmid: 17184768
references.citation: Annu Rev Physiol. 1995;57:707-36
references.pmid: 7539994